Krishnan Eswar, Tugwell Peter, Fries James F
Clinical Research Center of Reading, West Reading, PA, USA.
Arthritis Res Ther. 2004;6(6):R505-13. doi: 10.1186/ar1220. Epub 2004 Sep 14.
Physicians are in need of a simple objective, standardized tool to compare their patients with rheumatoid arthritis, as a group and individually, with national standards. The Disability Index of the Health Assessment Questionnaire (HAQ-DI) is a simple, robust tool that can fulfill these needs. However, use of this tool as a quality indicator (QI) is hampered by the unavailability of national reference values or benchmarks based on large, multicentric, heterogenous longitudinal patient cohorts. We utilized the 20-year longitudinal prospective data from 11 data banks of Arthritis Rheumatism and Aging Medical Information to calculate reference values for HAQ-DI. Overall, 6436 patients with rheumatoid arthritis were longitudinally followed for 32,324 person-years over the 20 years from 1981 to 2000. There were 64,647 HAQ-DI measurements, with an average of 19 measurements per person. Overall, 75% of patients were women and 89% were Caucasian; the median baseline age was 58.4 years and the median baseline HAQ-DI was 1.13. Few patients were treated with biologics. The HAQ-DI values had a Gaussian distribution except for the approximately 10% of observations showing no disability. Percentile benchmarks allow disability outcomes to be compared and contrasted between different patient populations. Reference values for the HAQ-DI, presented here numerically and graphically, can be used in clinical practice as a QI measure to track functional disability outcomes and to measure response to therapy, and by arthritis patients in self-management programs.
医生需要一种简单、客观、标准化的工具,以便将他们的类风湿关节炎患者群体和个体与国家标准进行比较。健康评估问卷残疾指数(HAQ-DI)是一种能够满足这些需求的简单而可靠的工具。然而,由于缺乏基于大型、多中心、异质性纵向患者队列的全国参考值或基准,该工具作为质量指标(QI)的使用受到了阻碍。我们利用来自关节炎、风湿病和衰老医学信息11个数据库的20年纵向前瞻性数据来计算HAQ-DI的参考值。总体而言,从1981年到2000年的20年中,对6436例类风湿关节炎患者进行了32324人年的纵向随访。共进行了64647次HAQ-DI测量,平均每人19次。总体而言,75%的患者为女性,89%为白种人;基线年龄中位数为58.4岁,基线HAQ-DI中位数为1.13。很少有患者接受生物制剂治疗。除了约10%的观察结果显示无残疾外,HAQ-DI值呈高斯分布。百分位数基准允许在不同患者群体之间比较和对比残疾结果。本文以数字和图形形式呈现的HAQ-DI参考值,可在临床实践中用作QI指标,以跟踪功能残疾结果并衡量治疗反应,也可供关节炎患者在自我管理项目中使用。